Clinical Trial Update: A Phase II Clinical Study to Evaluate the Efficacy and Safety of Flazoparib Combined With Temozolomide After the Completion of Standard Concurrent Chemoradiotherapy (CCRT) in Newly Diagnosed Glioblastoma [Phase 2]

View source ↗

Summary

Phase II clinical study assessing the efficacy and safety of combining flazoparib with temozolomide after standard chemoradiotherapy in newly diagnosed glioblas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Flazoparib (flazoparib)
• Temodar (Temozolomide)

Snippet

Sponsor: Tongji Hospital | Conditions: Glioblastoma | Phase 2 | Status: NOT_YET_RECRUITING